ASX - By Stock
|
RAP |
Re:
Ann: Quarterly Activities Report and Appendix 4C
|
|
Cosmoclarke
|
142 |
30K |
14 |
29/10/21 |
29/10/21 |
ASX - By Stock
|
142
|
30K
|
14
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Quarterly Activities Report and Appendix 4C
|
|
Cosmoclarke
|
142 |
30K |
1 |
28/10/21 |
28/10/21 |
ASX - By Stock
|
142
|
30K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Quarterly Activities Report and Appendix 4C
|
|
Cosmoclarke
|
142 |
30K |
2 |
28/10/21 |
28/10/21 |
ASX - By Stock
|
142
|
30K
|
2
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Quarterly Activities Report and Appendix 4C
|
|
Cosmoclarke
|
142 |
30K |
4 |
28/10/21 |
28/10/21 |
ASX - By Stock
|
142
|
30K
|
4
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Quarterly Activities Report and Appendix 4C
|
|
Cosmoclarke
|
142 |
30K |
3 |
28/10/21 |
28/10/21 |
ASX - By Stock
|
142
|
30K
|
3
|
|
ASX - By Stock
|
RAP |
Re:
COVID-19 Instant Screening test
|
|
Cosmoclarke
|
1.0K |
296K |
25 |
19/10/21 |
19/10/21 |
ASX - By Stock
|
1.0K
|
296K
|
25
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResApp announces FDA 510(k) submission for SleepCheckRx
|
|
Cosmoclarke
|
74 |
25K |
4 |
11/10/21 |
11/10/21 |
ASX - By Stock
|
74
|
25K
|
4
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResApp announces FDA 510(k) submission for SleepCheckRx
|
|
Cosmoclarke
|
74 |
25K |
6 |
11/10/21 |
11/10/21 |
ASX - By Stock
|
74
|
25K
|
6
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResApp announces FDA 510(k) submission for SleepCheckRx
|
|
Cosmoclarke
|
74 |
25K |
8 |
11/10/21 |
11/10/21 |
ASX - By Stock
|
74
|
25K
|
8
|
|
ASX - By Stock
|
RAP |
Re:
RAP media thread.
|
|
Cosmoclarke
|
3.3K |
2.5M |
13 |
09/10/21 |
09/10/21 |
ASX - By Stock
|
3.3K
|
2.5M
|
13
|
|
ASX - By Stock
|
RAP |
Re:
RAP media thread.
|
|
Cosmoclarke
|
3.3K |
2.5M |
3 |
08/10/21 |
08/10/21 |
ASX - By Stock
|
3.3K
|
2.5M
|
3
|
|
ASX - By Stock
|
RAP |
Re:
COVID-19 Instant Screening test
|
|
Cosmoclarke
|
1.0K |
296K |
2 |
07/10/21 |
07/10/21 |
ASX - By Stock
|
1.0K
|
296K
|
2
|
|
ASX - By Stock
|
RAP |
Re:
COVID-19 Instant Screening test
|
|
Cosmoclarke
|
1.0K |
296K |
2 |
05/10/21 |
05/10/21 |
ASX - By Stock
|
1.0K
|
296K
|
2
|
|
ASX - By Stock
|
RAP |
Re:
Ann: First patients recruited in COVID-19 clinical study in India
|
|
Cosmoclarke
|
86 |
29K |
1 |
28/09/21 |
28/09/21 |
ASX - By Stock
|
86
|
29K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Ann: First patients recruited in COVID-19 clinical study in India
|
|
Cosmoclarke
|
86 |
29K |
0 |
24/09/21 |
24/09/21 |
ASX - By Stock
|
86
|
29K
|
0
|
|
ASX - By Stock
|
RAP |
Re:
Ann: First patients recruited in COVID-19 clinical study in India
|
|
Cosmoclarke
|
86 |
29K |
18 |
22/09/21 |
22/09/21 |
ASX - By Stock
|
86
|
29K
|
18
|
|
ASX - By Stock
|
RAP |
Re:
ResApp could be the future of COVID-19 screening
|
|
Cosmoclarke
|
181 |
60K |
2 |
13/09/21 |
13/09/21 |
ASX - By Stock
|
181
|
60K
|
2
|
|
ASX - By Stock
|
RAP |
Re:
rap chart
|
|
Cosmoclarke
|
4.6K |
2.1M |
7 |
10/09/21 |
10/09/21 |
ASX - By Stock
|
4.6K
|
2.1M
|
7
|
|
ASX - By Stock
|
RAP |
Re:
Price Hike
|
|
Cosmoclarke
|
94 |
30K |
0 |
08/09/21 |
08/09/21 |
ASX - By Stock
|
94
|
30K
|
0
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Medgate enters licence agreement with ResApp Health
|
|
Cosmoclarke
|
122 |
41K |
0 |
07/09/21 |
07/09/21 |
ASX - By Stock
|
122
|
41K
|
0
|
|
ASX - By Stock
|
RAP |
Re:
rap chart
|
|
Cosmoclarke
|
4.6K |
2.1M |
21 |
07/09/21 |
07/09/21 |
ASX - By Stock
|
4.6K
|
2.1M
|
21
|
|
ASX - By Stock
|
RAP |
Re:
rap chart
|
|
Cosmoclarke
|
4.6K |
2.1M |
6 |
07/09/21 |
07/09/21 |
ASX - By Stock
|
4.6K
|
2.1M
|
6
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResAppDx receives regulatory approval in Indonesia
|
|
Cosmoclarke
|
60 |
21K |
4 |
02/09/21 |
02/09/21 |
ASX - By Stock
|
60
|
21K
|
4
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Appendix 4E and Annual Report
|
|
Cosmoclarke
|
38 |
10K |
5 |
28/08/21 |
28/08/21 |
ASX - By Stock
|
38
|
10K
|
5
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Investor Webinar Presentation
|
|
Cosmoclarke
|
159 |
44K |
2 |
27/08/21 |
27/08/21 |
ASX - By Stock
|
159
|
44K
|
2
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Investor Webinar Presentation
|
|
Cosmoclarke
|
159 |
44K |
1 |
27/08/21 |
27/08/21 |
ASX - By Stock
|
159
|
44K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Investor Webinar Presentation
|
|
Cosmoclarke
|
159 |
44K |
1 |
27/08/21 |
27/08/21 |
ASX - By Stock
|
159
|
44K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Investor Webinar Presentation
|
|
Cosmoclarke
|
159 |
44K |
3 |
27/08/21 |
27/08/21 |
ASX - By Stock
|
159
|
44K
|
3
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Investor Webinar Presentation
|
|
Cosmoclarke
|
159 |
44K |
0 |
24/08/21 |
24/08/21 |
ASX - By Stock
|
159
|
44K
|
0
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Investor Webinar Presentation
|
|
Cosmoclarke
|
159 |
44K |
7 |
24/08/21 |
24/08/21 |
ASX - By Stock
|
159
|
44K
|
7
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Investor Webinar Presentation
|
|
Cosmoclarke
|
159 |
44K |
2 |
23/08/21 |
23/08/21 |
ASX - By Stock
|
159
|
44K
|
2
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Investor Webinar Presentation
|
|
Cosmoclarke
|
159 |
44K |
7 |
23/08/21 |
23/08/21 |
ASX - By Stock
|
159
|
44K
|
7
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Investor Webinar Presentation
|
|
Cosmoclarke
|
159 |
44K |
14 |
23/08/21 |
23/08/21 |
ASX - By Stock
|
159
|
44K
|
14
|
|
ASX - By Stock
|
RAP |
Re:
RAP media thread.
|
|
Cosmoclarke
|
3.3K |
2.5M |
6 |
15/08/21 |
15/08/21 |
ASX - By Stock
|
3.3K
|
2.5M
|
6
|
|
ASX - By Stock
|
RAP |
Re:
Subscription vs. Price per Cough
|
|
Cosmoclarke
|
67 |
18K |
27 |
11/08/21 |
11/08/21 |
ASX - By Stock
|
67
|
18K
|
27
|
|
ASX - By Stock
|
RAP |
Re:
RAP media thread.
|
|
Cosmoclarke
|
3.3K |
2.5M |
1 |
27/07/21 |
27/07/21 |
ASX - By Stock
|
3.3K
|
2.5M
|
1
|
|
ASX - By Stock
|
RAP |
Re:
RAP media thread.
|
|
Cosmoclarke
|
3.3K |
2.5M |
2 |
22/07/21 |
22/07/21 |
ASX - By Stock
|
3.3K
|
2.5M
|
2
|
|
ASX - By Stock
|
RAP |
Re:
RAP media thread.
|
|
Cosmoclarke
|
3.3K |
2.5M |
16 |
21/07/21 |
21/07/21 |
ASX - By Stock
|
3.3K
|
2.5M
|
16
|
|
ASX - By Stock
|
RAP |
Re:
RAP media thread.
|
|
Cosmoclarke
|
3.3K |
2.5M |
7 |
21/07/21 |
21/07/21 |
ASX - By Stock
|
3.3K
|
2.5M
|
7
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Commercial agreement with Doctors on Demand in Australia
|
|
Cosmoclarke
|
88 |
30K |
19 |
05/07/21 |
05/07/21 |
ASX - By Stock
|
88
|
30K
|
19
|
|
ASX - By Stock
|
RAP |
Re:
rap chart
|
|
Cosmoclarke
|
4.6K |
2.1M |
7 |
01/07/21 |
01/07/21 |
ASX - By Stock
|
4.6K
|
2.1M
|
7
|
|
ASX - By Stock
|
RAP |
Re:
rap chart
|
|
Cosmoclarke
|
4.6K |
2.1M |
5 |
23/06/21 |
23/06/21 |
ASX - By Stock
|
4.6K
|
2.1M
|
5
|
|
ASX - By Stock
|
RAP |
Re:
RAP media thread.
|
|
Cosmoclarke
|
3.3K |
2.5M |
10 |
22/06/21 |
22/06/21 |
ASX - By Stock
|
3.3K
|
2.5M
|
10
|
|
ASX - By Stock
|
RAP |
Re:
RAP media thread.
|
|
Cosmoclarke
|
3.3K |
2.5M |
7 |
21/06/21 |
21/06/21 |
ASX - By Stock
|
3.3K
|
2.5M
|
7
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Medgate commences European ResAppDx trial
|
|
Cosmoclarke
|
167 |
59K |
0 |
01/06/21 |
01/06/21 |
ASX - By Stock
|
167
|
59K
|
0
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Medgate commences European ResAppDx trial
|
|
Cosmoclarke
|
167 |
59K |
3 |
31/05/21 |
31/05/21 |
ASX - By Stock
|
167
|
59K
|
3
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Brian Leedman Reappointed as Executive Director
|
|
Cosmoclarke
|
63 |
21K |
4 |
18/05/21 |
18/05/21 |
ASX - By Stock
|
63
|
21K
|
4
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Brian Leedman Reappointed as Executive Director
|
|
Cosmoclarke
|
63 |
21K |
6 |
18/05/21 |
18/05/21 |
ASX - By Stock
|
63
|
21K
|
6
|
|
ASX - By Stock
|
RAP |
Re:
Ann: First participant recruited in COVID-19 cough study
|
|
Cosmoclarke
|
42 |
14K |
2 |
17/05/21 |
17/05/21 |
ASX - By Stock
|
42
|
14K
|
2
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Agreement with Ilara Health to sell ResAppDx in Kenya
|
|
Cosmoclarke
|
224 |
51K |
2 |
04/05/21 |
04/05/21 |
ASX - By Stock
|
224
|
51K
|
2
|
|